This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1lky

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1lky.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:1lky.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1lky| PDB=1lky | SCENE= }}
{{STRUCTURE_1lky| PDB=1lky | SCENE= }}
-
'''Structure of the wild-type TEL-SAM polymer'''
+
===Structure of the wild-type TEL-SAM polymer===
-
==Overview==
+
<!--
-
BACKGROUND: TEL is a transcriptional repressor containing a SAM domain that forms a helical polymer. In a number of hematologic malignancies, chromosomal translocations lead to aberrant fusions of TEL-SAM to a variety of other proteins, including many tyrosine kinases. TEL-SAM polymerization results in constitutive activation of the tyrosine kinase domains to which it becomes fused, leading to cell transformation. Thus, inhibitors of TEL-SAM self-association could abrogate transformation in these cells. In previous work, we determined the structure of a mutant TEL-SAM polymer bearing a Val to Glu substitution in center of the subunit interface. It remained unclear how much the mutation affected the architecture of the polymer, however. RESULTS: Here we determine the structure of the native polymer interface. To accomplish this goal, we introduced mutations that block polymer extension, producing a heterodimer with a wild-type interface. We find that the structure of the wild-type polymer interface is quite similar to the mutant structure determined previously. With the structure of the native interface, it is possible to evaluate the potential for developing therapeutic inhibitors of the interaction. We find that the interacting surfaces of the protein are relatively flat, containing no obvious pockets for the design of small molecule inhibitors. CONCLUSION: Our results confirm the architecture of the TEL-SAM polymer proposed previously based on a mutant structure. The fact that the interface contains no obvious potential binding pockets suggests that it may be difficult to find small molecule inhibitors to treat malignancies in this way.
+
The line below this paragraph, {{ABSTRACT_PUBMED_12193272}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 12193272 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_12193272}}
==About this Structure==
==About this Structure==
Line 30: Line 34:
[[Category: Transcriptional repression]]
[[Category: Transcriptional repression]]
[[Category: Tyrosine kinase]]
[[Category: Tyrosine kinase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 00:01:16 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul 2 21:21:05 2008''

Revision as of 18:21, 2 July 2008

Image:1lky.png

Template:STRUCTURE 1lky

Structure of the wild-type TEL-SAM polymer

Template:ABSTRACT PUBMED 12193272

About this Structure

1LKY is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Native interface of the SAM domain polymer of TEL., Tran HH, Kim CA, Faham S, Siddall MC, Bowie JU, BMC Struct Biol. 2002 Aug 22;2:5. PMID:12193272

Page seeded by OCA on Wed Jul 2 21:21:05 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1lky"
Personal tools